Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer

(2023) Alvaro Arjona-Sánchez et al.   JAMA Surgery

Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study – protocol for a randomised, multicentre, phase 3 trial

(2022) Fabio Pacelli et al.   BMJ Open

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

(2021) François Quénet et al.   LANCET ONCOLOGY

Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study

(2020) Diane Goéré et al.   LANCET ONCOLOGY

Preventive intraperitoneal hyperthermic perfusion chemotherapy for patients with T4 stage colon adenocarcinoma

(2020) T. Li et al.   Techniques in Coloproctology

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines

(2020) Roxan F.C.P.A. Helderman et al.   Cells

Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial

(2019) Vivian P. Bastiaenen et al.   BMC CANCER

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

(2019) I. Ubink et al.   BRITISH JOURNAL OF SURGERY

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

(2019) Charlotte E L Klaver et al.   Lancet Gastroenterology & Hepatology

523OFOxTROT: An international randomised controlled trial in 1053 patients evaluating neoadjuvant chemotherapy (NAC) for colon cancer. On behalf of the FOxTROT Collaborative Group

(2019) D Morton   ANNALS OF ONCOLOGY

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

(2018) A. Arjona-Sánchez et al.   BMC CANCER

Challenging the dogma of colorectal peritoneal metastases as an untreatable condition: Results of a population-based study

(2016) Lieke G.E.M. Razenberg et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial

(2015) Charlotte E L Klaver et al.   BMC CANCER

Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study

(2015) Claus Anders Bertelsen et al.   LANCET ONCOLOGY

Peritoneal Carcinomatosis in T4 Colorectal Cancer: Occurrence and Risk Factors

(2014) H. C. van Santvoort et al.   ANNALS OF SURGICAL ONCOLOGY

Intraperitoneal chemotherapy as adjuvant treatment to prevent peritoneal carcinomatosis of colorectal cancer origin: a systematic review

(2014) D A M Sloothaak et al.   BRITISH JOURNAL OF CANCER

Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer

(2013) Y.R.B.M. van Gestel et al.   EJSO